218 related articles for article (PubMed ID: 7673613)
21. Omeprazole, amoxicillin and bismuth for peptic ulcer healing and Helicobacter pylori eradication.
Treiber G; Walker S; Klotz U
Arzneimittelforschung; 1997 Jan; 47(1):47-50. PubMed ID: 9037444
[TBL] [Abstract][Full Text] [Related]
22. Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.
Feng LY; Yao XX; Jiang SL
World J Gastroenterol; 2005 Feb; 11(7):1083-6. PubMed ID: 15742421
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
[TBL] [Abstract][Full Text] [Related]
24. Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin.
Uemura N; Okamoto S; Mukai T; Yamaguchi S; Kaji M; Hrruma K; Sumii K; Kajiyama G
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S67-9. PubMed ID: 8574740
[TBL] [Abstract][Full Text] [Related]
25. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319
[No Abstract] [Full Text] [Related]
26. Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.
Gremse DA
Expert Opin Pharmacother; 2001 Oct; 2(10):1663-70. PubMed ID: 11825309
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer.
Fanti L; Ieri R; Mezzi G; Testoni PA; Passaretti S; Guslandi M
J Clin Gastroenterol; 2001 Jan; 32(1):45-8. PubMed ID: 11154169
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of lansoprazole against peptic ulcers induced by non-steroidal anti-inflammatory drugs: endoscopic evaluation of ulcer healing.
Matsukawa Y; Tomita Y; Nishinarita S; Horie T; Kato K; Arakawa Y; Ko K; Shimada H; Nakano M; Kitami Y; Kurosaka H
J Int Med Res; 1997; 25(4):190-5. PubMed ID: 9283991
[TBL] [Abstract][Full Text] [Related]
29. Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy.
Saita H; Murakami M; Takahashi Y; Sou Y; Kaitani K; Nishio K; Kita T
J Gastroenterol Hepatol; 1998 Jul; 13(7):725-31. PubMed ID: 9715425
[TBL] [Abstract][Full Text] [Related]
30. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
31. [Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
Iwasaki A
Nihon Rinsho; 1999 Jan; 57(1):127-33. PubMed ID: 10036949
[TBL] [Abstract][Full Text] [Related]
32. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
33. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
34. One-week once-daily triple therapy for Helicobacter pylori--a pilot study.
Chu KM; Kwok KF; Law SY; Wong J
Hepatogastroenterology; 2000; 47(36):1624-6. PubMed ID: 11149018
[TBL] [Abstract][Full Text] [Related]
35. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy of lansoprazole-amoxicillin treatment in eradicating Helicobacter pylori: evaluation by the polymerase chain reaction method.
Shimada T; Ogura K; Ota S; Terano A
J Clin Gastroenterol; 1995; 20 Suppl 2():S100-3. PubMed ID: 7594321
[TBL] [Abstract][Full Text] [Related]
37. Eradication of Helicobacter pylori with lansoprazole based triple therapy in peptic ulcer disease.
Kullavanijaya P; Gonlachanvit S; Mahachai V; Kladchareon N
J Med Assoc Thai; 2000 Mar; 83(3):230-5. PubMed ID: 10808676
[TBL] [Abstract][Full Text] [Related]
38. Low dose, short-term, triple therapy for helicobacter pylori associated peptic ulcer.
Zuberi BF; Lal S; Sheikh RM
J Pak Med Assoc; 1997 Sep; 47(9):228-30. PubMed ID: 9361485
[TBL] [Abstract][Full Text] [Related]
39. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A
J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322
[TBL] [Abstract][Full Text] [Related]
40. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
